Sun Pharmaceutical Industries has strengthened its global opiates manufacturing business with the acquisition of two Australian manufacturing facilities from GlaxoSmithKline. …

Australia’s drug regulator says it will not be updating its safety advice for Boehringer’s Pradaxa despite mounting safety issues around …

Pfizer has a legal battle on its hands in Australia, where the country’s consumer watchdog has begun proceedings in the …

A GlaxoSmithKline tablet packaging facility in Australia will be closed with the loss of 120 jobs, around a third of …
Australia’s pharmaceutical industry is urging the country’s legislators to pass a new medicines pricing bill that aims to save Aus$1.9 …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

